Bone Disorder

Fx Risk Should Be Monitored in Bisphosphonate Drug Holiday

May 11, 2018

The researchers found that 15.4% of the patients developed a fracture during follow-up. Yearly fracture incidence varied from 3.7 to 9.9%, peaking during years four and five at 9.9 and 9.8%, respectively.

Fulranumab for Osteoarthritis Pain

By March 08, 2017

Sanga, Panna MD et al. "Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-to-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study"

Hormone ID'd as Link Between Bone and Vascular Disease

January 11, 2017

Significant association with carotid-femoral pulse wave velocity persists after multivariable adjustment